Skip to main content

Bhattacharya says ‘I trust the science’ on childhood vaccines

▶ Watch Video: NIH Director Dr. Jay Bhattacharya says “I trust the science” on childhood vaccines

Washington — Dr. Jay Bhattacharya, director of the National Institutes of Health, said on Sunday that “I trust the science” on vaccines, as measles cases have risen to their highest levels in 35 years, sparking concern among some parents about their children returning to school this fall. 

“I think that parents, for most kids, especially for the measles vaccines, the DTP, all the standard childhood vaccines, it’s very important that parents vaccinate their kids,” Bhattacharya said on “Face the Nation with Margaret Brennan.”

Bhattacharya, who had also been serving as acting CDC director in recent months, said, “I’m giving my recommendation — I’ve vaccinated my kids.”

“I think if you want to protect your kids from these sort of preventable diseases, yes, you should vaccinate your kids,” he said. “But it is even more important that these kids go to school.”

Bhattacharya pointed to the COVID-19 pandemic and the loss of trust in public health officials and institutions. He argued that it was a “tremendous mistake” to cause parents to fear sending their kids to school at the time. And as he encouraged parents to vaccinate their children, he said “it is a mistake, and it contributes to lack of public trust if you sort of fearmonger around, ‘Oh, if you send your kids to school, well, you might be around unvaccinated kids.'”

“That’s a tremendous mistake,” he said. “You vaccinate your kids, you can protect your kids from those risks, whatever they are.”

As measles cases have risen to their highest rates in decades in recent years, just 10 states had measles coverage rates among kindergarteners above the 95% threshold required for so-called herd immunity during the 2024-2025 school year, according to the CDC. When pressed by Margaret Brennan about what the administration can do, like a national push to share widely HHS Secretary Robert F. Kennedy Jr.’s message that he shared on CNN last week that parents should get their kids vaccinated against measles, Bhattacharya said “I’ve done my best to try to do that.”

“Every time anyone’s asked me about vaccinating their kids for measles, I say exactly that,” he said. “The best way to protect your kids from measles is to get the vaccine for measles.”

Bhattacharya noted that one of his first actions as acting CDC director in February was to go on camera and recommend that the best way to end the measles outbreak in South Carolina was for kids to get vaccinated, saying “the outbreak has now ended in South Carolina in part because of that.”

Bhattacharya stressed that outbreaks in specific states have been addressed. 

“Big outbreak in Texas, which has now been addressed; big outbreak in Arizona and Utah, that’s been addressed; South Carolina, that’s been addressed,” he said. “Now, we saw there’s an outbreak in Virginia, again coming down sharply, and now Pennsylvania. It’s specific communities of people that are the highest risk that we have to focus on, as well as the broader sort of message that it’s important for children to be vaccinated for the measles.”

Bhattacharya’s comments came after reports the White House is drafting an executive order on childhood vaccines and autism. Bhattacharya deferred to the White House on the details of the executive order, noting that “I won’t be able to tell you specifically what’s on it because I don’t think it’s done yet.” But he stressed that the president and HHS secretary care “deeply” about the rise in autism.

“I, as NIH director, have been focused on making sure that we have science that addresses that very complicated question about why we’ve seen a rise in autism,” Bhattacharya said. “It’s not going to be a simple answer.”

He added, “If you ask me, as a scientist, do I know why we’ve seen this rise in autism, I’ll tell you, I don’t know the answer to that question. And the fact that it gets so tied up with OK, is it is it vaccines not vaccines, what it does is it sends a signal to scientists that if you work on this topic, you’re going to get destroyed if you get the wrong answer.”

“The way you build public trust is, allow people to talk and think without that kind of sort of political overlay,” Bhattacharya said. “I’ve tried my very hardest as NIH director to allow that to happen.”

Kennedy is a longtime critic of vaccines, and has promoted the previously debunked connection between vaccines and autism. 

Britain’s giving Ukraine access to secret missile technology. Will it make a difference?

(CNN) — Britain will allow the release of classified technology so that a British/French-designed cruise missile can be manufactured in Ukraine, a boost for Kyiv in its efforts to bring more firepower to bear hundreds of kilometers into Russia.Paris and Kyiv want to set up a Ukrainian production line for the SCALP air-launched cruise missile, known as the Storm Shadow in the United Kingdom, by the end of the year. The declassification of information on British-made components of the missiles, announced Monday, is a key step towards that goal.Made by European arms manufacturer MBDA, SCALP is a conventionally armed, long-range, deep-strike weapon, of which Ukraine has used imported versions with success against hardened targets, including in November 2024, when they were fired at targets inside Russia for the first time.Powered by a turbojet engine, it has a maximum range of 550 kilometers (342 miles) and can carry a 400-kilogram (880 pounds) high-explosive penetrating warhead, according to the Missile Threat project at the Center for Strategic and International Studies (CSIS)Once launched, the missile uses a combination of internal, global positioning and terrain reference navigation coupled with “infrared seeker and automatic target recognition algorithms” to achieve a high degree of accuracy in all weather conditions, according to the CSIS.The SCALP is fired from Ukraine’s Su-24 or Mirage 2000 fighter jets and attempts to avoid air defenses by hugging the terrain during flight.Its use for Ukraine will be in striking buried military targets, like command bunkers, something more challenging for the lighter weight drones Kyiv has been using to hit more exposed targets like oil refineries or warehouses.Britain and France have not announced how many SCALP/Storm Shadow missiles have been supplied to Ukraine to date, but in 2025 manufacturer MBDA reactivated production lines that had been shuttered for 15 years.“Supplied to Ukraine, the Franco-British SCALP/Storm Shadow missile has demonstrated its effectiveness in modern high-intensity combat, in decisive situations,” French Defense Minister Sébastien Lecornu said at the time.Even with the UK announcement, it could take several years for production to scale up, but British Prime Minister Andy Burnham says London is backing Kyiv for the long haul.“The Ukrainian people should be in no doubt: the UK is behind you today and for as long as it takes,” Burnham said in a press release Monday announcing that the UK would release its missile technology.“Ukraine’s security is our security,” said the prime minister, who arrived in Kyiv on Monday for Ukraine’s independence day, in his first overseas trip since taking office on July 20.While there, Burnham will co-chair a meeting of the Coalition of the Willing, a 34-nation international alliance formed last year by Britain and France to support Ukraine in the war as US aid waned under the Trump administration.Interceptor struggleWhat the SCALP can’t address is Ukraine’s shortage of defensive missiles, like the US-designed Patriot system, a vulnerability exposed with devastating consequences in recent weeks as Russia has launched large waves of its own missiles and drones in attacks that have killed dozens of Ukrainians.CNN visited a Patriot battery in Ukraine earlier this month and was told that it had not been fired in weeks because no interceptors were available.Ukraine has asked for permission to manufacture the Patriot interceptors in the country, an idea US President Donald Trump initially supported in early July but later backtracked on.The Trump administration has also rebuffed Ukrainian attempts to acquire long-range US Tomahawk cruise missiles, stocks of which have been taxed by the war in Iran.Ukraine’s domestic missile production has not stood still, however.Ukrainian manufacturer Fire Point has developed the FP-5 Flamingo cruise missile.With a range of 3,000 kilometers, it can strike deep inside Russia, and Ukrainian President Volodymyr Zelensky said earlier this month it was used to hit a key Russian rocket electronics facility some 900 kilometers from Ukraine’s border.The Ukrainian leader said the Flamingo made its combat debut in 2025, and open-source intelligence reports indicate its use has been on the increase this year.Fire Point has also developed long-range drones to go along with shorter range ballistic missiles.Kyiv’s use of longer-range weapons has turned Russia’s sprawling land mass, once considered a military advantage, into a problem for Moscow as it struggles to allocate limited defensive weaponry to the increasing number of targets within Ukraine’s range, Peter Dickinson, editor of the Atlantic Council’s Ukraine Alert blog, wrote earlier this month.“A long line of would-be conquerors have invaded Russia only for their armies to swallowed up by the vastness of the country. Ukraine is now attempting to turn this military logic on its head with a strategic bombing campaign that aims to exploit Russia’s immensity and transform it from a key strength into a fatal weakness,” Dickinson wrote.The-CNN-Wire™ & © 2026 Cable News Network, Inc., a Warner Bros. Discovery Company. All rights reserved.
Read Next Story